Altitude Crest Partners as of March 31, 2024
Portfolio Holdings for Altitude Crest Partners
Altitude Crest Partners holds 30 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 15.7 | $37M | 653k | 56.09 | |
| Danaher Corporation (DHR) | 11.6 | $27M | 109k | 249.72 | |
| Bridgebio Pharma (BBIO) | 8.1 | $19M | 612k | 30.92 | |
| Stevanato Group S P A Ord Shs (STVN) | 7.6 | $18M | 550k | 32.10 | |
| Apellis Pharmaceuticals (APLS) | 7.2 | $17M | 287k | 58.78 | |
| Thermo Fisher Scientific (TMO) | 4.6 | $11M | 18k | 581.21 | |
| Arrivent Biopharma (AVBP) | 4.2 | $9.9M | 556k | 17.86 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.8 | $8.8M | 205k | 42.86 | |
| Kiniksa Pharmaceuticals Com Cl A | 3.4 | $7.9M | 400k | 19.73 | |
| Janux Therapeutics (JANX) | 3.1 | $7.3M | 193k | 37.65 | |
| Eli Lilly & Co. (LLY) | 3.1 | $7.2M | 9.2k | 777.96 | |
| Biohaven (BHVN) | 2.8 | $6.5M | 118k | 54.69 | |
| Immunome (IMNM) | 2.8 | $6.5M | 262k | 24.68 | |
| Springworks Therapeutics (SWTX) | 2.7 | $6.3M | 129k | 49.22 | |
| Geron Corporation (GERN) | 2.2 | $5.1M | 1.5M | 3.30 | |
| Icon SHS (ICLR) | 2.1 | $5.0M | 15k | 335.95 | |
| Merus N V (MRUS) | 2.1 | $4.9M | 110k | 45.03 | |
| Roivant Sciences SHS (ROIV) | 2.1 | $4.8M | 455k | 10.54 | |
| Denali Therapeutics (DNLI) | 1.8 | $4.3M | 210k | 20.52 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.7 | $4.1M | 104k | 39.24 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $3.3M | 113k | 29.24 | |
| Day One Biopharmaceuticals I (DAWN) | 1.4 | $3.2M | 196k | 16.52 | |
| Aligos Therapeutics (ALGS) | 1.2 | $2.8M | 2.8M | 0.98 | |
| Engene Holdings (ENGN) | 0.9 | $2.0M | 120k | 16.95 | |
| Applied Therapeutics (APLT) | 0.8 | $1.8M | 260k | 6.80 | |
| Zymeworks Del (ZYME) | 0.7 | $1.5M | 146k | 10.52 | |
| Metagenomi (MGX) | 0.6 | $1.4M | 133k | 10.55 | |
| Tourmaline Bio (TRML) | 0.5 | $1.1M | 47k | 22.90 | |
| Alnylam Pharmaceuticals (ALNY) | 0.0 | $30k | 200.00 | 149.45 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $13k | 385k | 0.03 |
